↓ Skip to main content

Comparative Efficacy of Dapagliflozin and Empagliflozin of a Fixed Dose in Heart Failure: A Network Meta-Analysis

Overview of attention for article published in Frontiers in Cardiovascular Medicine, April 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (82nd percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

policy
1 policy source
twitter
7 X users
wikipedia
1 Wikipedia page

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
52 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Comparative Efficacy of Dapagliflozin and Empagliflozin of a Fixed Dose in Heart Failure: A Network Meta-Analysis
Published in
Frontiers in Cardiovascular Medicine, April 2022
DOI 10.3389/fcvm.2022.869272
Pubmed ID
Authors

Zepeng Shi, Feng Gao, Wei Liu, Xuezhi He

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 52 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 52 100%

Demographic breakdown

Readers by professional status Count As %
Other 6 12%
Student > Bachelor 4 8%
Student > Master 4 8%
Unspecified 2 4%
Student > Postgraduate 2 4%
Other 3 6%
Unknown 31 60%
Readers by discipline Count As %
Medicine and Dentistry 11 21%
Biochemistry, Genetics and Molecular Biology 2 4%
Unspecified 2 4%
Business, Management and Accounting 2 4%
Pharmacology, Toxicology and Pharmaceutical Science 1 2%
Other 4 8%
Unknown 30 58%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 February 2023.
All research outputs
#3,578,912
of 25,660,026 outputs
Outputs from Frontiers in Cardiovascular Medicine
#524
of 9,395 outputs
Outputs of similar age
#78,926
of 448,845 outputs
Outputs of similar age from Frontiers in Cardiovascular Medicine
#72
of 998 outputs
Altmetric has tracked 25,660,026 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 9,395 research outputs from this source. They receive a mean Attention Score of 4.4. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 448,845 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 998 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.